Skip to primary navigation
Skip to main content
Skip to footer
Baruch Future Ventures
Home
Team
Strategy
HVVC
Intrapreneur Investing
Advisory
Portfolio
Media
Codexis
Codexis expands advisory board for RNA synthesis platform
Codexis (NASDAQ:CDXS) Shares Pass Above 200-Day Moving Average of $2.25
Codexis Inc. Secures $40 Million Loan to Boost RNAi Therapeutics
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28